Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China

Abstract Background Mitochondria have been shown to play vital roles during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) development. Currently, it is unclear whether mitochondrial DNA (mtDNA) variants, which define mtDNA haplogroups...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yi Wu, Xian-Hui Wang, Xi-Hua Li, Li-Yuan Song, Shi-Long Yu, Zhi-Cheng Fang, Yu-Quan Liu, Le-Yong Yuan, Chun-Yan Peng, Shen-Yi Zhang, Wang Cheng, Hong-Chao Ma, Li-Feng Wang, Jun-Ming Tang, Yun-Fu Wang, Fu-Yun Ji
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
U
Acceso en línea:https://doaj.org/article/33d8fccb16bf4eedaff444b853677db1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:33d8fccb16bf4eedaff444b853677db1
record_format dspace
spelling oai:doaj.org-article:33d8fccb16bf4eedaff444b853677db12021-11-08T10:59:04ZCommon mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China10.1186/s40779-021-00351-22054-9369https://doaj.org/article/33d8fccb16bf4eedaff444b853677db12021-11-01T00:00:00Zhttps://doi.org/10.1186/s40779-021-00351-2https://doaj.org/toc/2054-9369Abstract Background Mitochondria have been shown to play vital roles during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) development. Currently, it is unclear whether mitochondrial DNA (mtDNA) variants, which define mtDNA haplogroups and determine oxidative phosphorylation performance and reactive oxygen species production, are associated with COVID-19 risk. Methods A population-based case–control study was conducted to compare the distribution of mtDNA variations defining mtDNA haplogroups between healthy controls (n = 615) and COVID-19 patients (n = 536). COVID-19 patients were diagnosed based on molecular diagnostics of the viral genome by qPCR and chest X-ray or computed tomography scanning. The exclusion criteria for the healthy controls were any history of disease in the month preceding the study assessment. MtDNA variants defining mtDNA haplogroups were identified by PCR-RFLPs and HVS-I sequencing and determined based on mtDNA phylogenetic analysis using Mitomap Phylogeny. Student’s t-test was used for continuous variables, and Pearson’s chi-squared test or Fisher’s exact test was used for categorical variables. To assess the independent effect of each mtDNA variant defining mtDNA haplogroups, multivariate logistic regression analyses were performed to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) with adjustments for possible confounding factors of age, sex, smoking and diseases (including cardiopulmonary diseases, diabetes, obesity and hypertension) as determined through clinical and radiographic examinations. Results Multivariate logistic regression analyses revealed that the most common investigated mtDNA variations (> 10% in the control population) at C5178a (in NADH dehydrogenase subunit 2 gene, ND2) and A249d (in the displacement loop region, D-loop)/T6392C (in cytochrome c oxidase I gene, CO1)/G10310A (in ND3) were associated with a reduced risk of severe COVID-19 (OR = 0.590, 95% CI 0.428–0.814, P = 0.001; and OR = 0.654, 95% CI 0.457–0.936, P = 0.020, respectively), while A4833G (ND2), A4715G (ND2), T3394C (ND1) and G5417A (ND2)/C16257a (D-loop)/C16261T (D-loop) were related to an increased risk of severe COVID-19 (OR = 2.336, 95% CI 1.179–4.608, P = 0.015; OR = 2.033, 95% CI 1.242–3.322, P = 0.005; OR = 3.040, 95% CI 1.522–6.061, P = 0.002; and OR = 2.890, 95% CI 1.199–6.993, P = 0.018, respectively). Conclusions This is the first study to explore the association of mtDNA variants with individual’s risk of developing severe COVID-19. Based on the case–control study, we concluded that the common mtDNA variants at C5178a and A249d/T6392C/G10310A might contribute to an individual’s resistance to developing severe COVID-19, whereas A4833G, A4715G, T3394C and G5417A/C16257a/C16261T might increase an individual’s risk of developing severe COVID-19.Yi WuXian-Hui WangXi-Hua LiLi-Yuan SongShi-Long YuZhi-Cheng FangYu-Quan LiuLe-Yong YuanChun-Yan PengShen-Yi ZhangWang ChengHong-Chao MaLi-Feng WangJun-Ming TangYun-Fu WangFu-Yun JiBMCarticleMtDNA variationsSARS-CoV-2COVID-19RiskHan ChineseMedicine (General)R5-920Military ScienceUENMilitary Medical Research, Vol 8, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic MtDNA variations
SARS-CoV-2
COVID-19
Risk
Han Chinese
Medicine (General)
R5-920
Military Science
U
spellingShingle MtDNA variations
SARS-CoV-2
COVID-19
Risk
Han Chinese
Medicine (General)
R5-920
Military Science
U
Yi Wu
Xian-Hui Wang
Xi-Hua Li
Li-Yuan Song
Shi-Long Yu
Zhi-Cheng Fang
Yu-Quan Liu
Le-Yong Yuan
Chun-Yan Peng
Shen-Yi Zhang
Wang Cheng
Hong-Chao Ma
Li-Feng Wang
Jun-Ming Tang
Yun-Fu Wang
Fu-Yun Ji
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China
description Abstract Background Mitochondria have been shown to play vital roles during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) development. Currently, it is unclear whether mitochondrial DNA (mtDNA) variants, which define mtDNA haplogroups and determine oxidative phosphorylation performance and reactive oxygen species production, are associated with COVID-19 risk. Methods A population-based case–control study was conducted to compare the distribution of mtDNA variations defining mtDNA haplogroups between healthy controls (n = 615) and COVID-19 patients (n = 536). COVID-19 patients were diagnosed based on molecular diagnostics of the viral genome by qPCR and chest X-ray or computed tomography scanning. The exclusion criteria for the healthy controls were any history of disease in the month preceding the study assessment. MtDNA variants defining mtDNA haplogroups were identified by PCR-RFLPs and HVS-I sequencing and determined based on mtDNA phylogenetic analysis using Mitomap Phylogeny. Student’s t-test was used for continuous variables, and Pearson’s chi-squared test or Fisher’s exact test was used for categorical variables. To assess the independent effect of each mtDNA variant defining mtDNA haplogroups, multivariate logistic regression analyses were performed to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) with adjustments for possible confounding factors of age, sex, smoking and diseases (including cardiopulmonary diseases, diabetes, obesity and hypertension) as determined through clinical and radiographic examinations. Results Multivariate logistic regression analyses revealed that the most common investigated mtDNA variations (> 10% in the control population) at C5178a (in NADH dehydrogenase subunit 2 gene, ND2) and A249d (in the displacement loop region, D-loop)/T6392C (in cytochrome c oxidase I gene, CO1)/G10310A (in ND3) were associated with a reduced risk of severe COVID-19 (OR = 0.590, 95% CI 0.428–0.814, P = 0.001; and OR = 0.654, 95% CI 0.457–0.936, P = 0.020, respectively), while A4833G (ND2), A4715G (ND2), T3394C (ND1) and G5417A (ND2)/C16257a (D-loop)/C16261T (D-loop) were related to an increased risk of severe COVID-19 (OR = 2.336, 95% CI 1.179–4.608, P = 0.015; OR = 2.033, 95% CI 1.242–3.322, P = 0.005; OR = 3.040, 95% CI 1.522–6.061, P = 0.002; and OR = 2.890, 95% CI 1.199–6.993, P = 0.018, respectively). Conclusions This is the first study to explore the association of mtDNA variants with individual’s risk of developing severe COVID-19. Based on the case–control study, we concluded that the common mtDNA variants at C5178a and A249d/T6392C/G10310A might contribute to an individual’s resistance to developing severe COVID-19, whereas A4833G, A4715G, T3394C and G5417A/C16257a/C16261T might increase an individual’s risk of developing severe COVID-19.
format article
author Yi Wu
Xian-Hui Wang
Xi-Hua Li
Li-Yuan Song
Shi-Long Yu
Zhi-Cheng Fang
Yu-Quan Liu
Le-Yong Yuan
Chun-Yan Peng
Shen-Yi Zhang
Wang Cheng
Hong-Chao Ma
Li-Feng Wang
Jun-Ming Tang
Yun-Fu Wang
Fu-Yun Ji
author_facet Yi Wu
Xian-Hui Wang
Xi-Hua Li
Li-Yuan Song
Shi-Long Yu
Zhi-Cheng Fang
Yu-Quan Liu
Le-Yong Yuan
Chun-Yan Peng
Shen-Yi Zhang
Wang Cheng
Hong-Chao Ma
Li-Feng Wang
Jun-Ming Tang
Yun-Fu Wang
Fu-Yun Ji
author_sort Yi Wu
title Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China
title_short Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China
title_full Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China
title_fullStr Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China
title_full_unstemmed Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China
title_sort common mtdna variations at c5178a and a249d/t6392c/g10310a decrease the risk of severe covid-19 in a han chinese population from central china
publisher BMC
publishDate 2021
url https://doaj.org/article/33d8fccb16bf4eedaff444b853677db1
work_keys_str_mv AT yiwu commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT xianhuiwang commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT xihuali commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT liyuansong commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT shilongyu commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT zhichengfang commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT yuquanliu commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT leyongyuan commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT chunyanpeng commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT shenyizhang commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT wangcheng commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT hongchaoma commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT lifengwang commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT junmingtang commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT yunfuwang commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
AT fuyunji commonmtdnavariationsatc5178aanda249dt6392cg10310adecreasetheriskofseverecovid19inahanchinesepopulationfromcentralchina
_version_ 1718442409909551104